← Back to headlines
Tango Therapeutics Benefits From Pancreatic Cancer Data
Tango Therapeutics (TNGX) is expected to benefit from an upcoming data announcement related to pancreatic ductal adenocarcinoma.
5 Jun, 15:55 — 5 Jun, 15:55
Sources
Showing 1 of 1 sources
